long term efficacy of enzyme replacement therapy (ert) in gaucher disease type 1 and type 3
Published 1 year ago • 713 plays • Length 4:39Download video MP4
Download video MP3
Similar videos
-
4:23
treating gaucher disease type 3: a history lesson
-
2:47
gaucher disease type 1, type 2, and type 3 explained
-
10:53
gaucher disease explained
-
3:33
cardiovascular problems and gaucher disease type 3: highlights from worldsymposium 2020
-
4:20
dr. pramod mistry discusses biomarkers as they pertain to patients with type 1 gaucher disease
-
5:30
gaucher disease - causes, symptoms, diagnosis, treatment, pathology
-
17:16
gaucher disease: signs and symptoms (module 1)
-
4:44
gene therapy vs enzyme replacement therapy for fabry disease
-
1:55
current treatment options for children with gaucher disease type 2
-
3:23
gene therapy trials for gaucher type 1 and type 2 now recruiting
-
1:37
enzyme replacement therapy versus gene therapy
-
6:56
gene therapy and gaucher disease: highlights from worldsymposium 2020
-
1:50
dr. zimran discusses biomarkers in gaucher disease
-
5:00
gaucher type 2, enzyme replacement therapy: how it helped quality of life.
-
1:22
which patients with gaucher disease switching to the oral treatment option?
-
4:00
dr. pramod mistry provides a 4.5-year update of the engage trial
-
1:34
diagnosing gaucher disease still a problem
-
3:59
understanding how therapy for gaucher disease works